At this time, posts about Celltrion Healthcare are rapidly increasing on portals and stock communities. Today, foreigners have tentatively been recorded as net buyers of 25,000 shares of Celltrion Healthcare, while institutions have been net sellers of 16,000 shares. Celltrion Healthcare is known as the exclusive distributor of Celltrion's biosimilars.


As of 1:30 PM on the 4th, the stock price of Celltrion Healthcare is 154,400 KRW, down 5.28% from the previous day, with a trading volume of 4,353,685 shares, which is about 70.95% of the 5-day average trading volume.


In addition to Celltrion Healthcare, posts by investors are also surging for KMH (122450), L&K Bio (156100), and WIZIT (036090).



※Source: AI Investment Assistant AI Lassiro


※ This article was generated in real-time by an automatic article generation algorithm jointly developed by Asia Economy and the financial AI specialist company Thinkpool.


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing